IHC staining revealed elevated SUSD2 protein levels in tissues from a patient (Case 1) with EGFR+ HER2+ breast cancer compared to tissues from a patient (Case 2) with EGFR+ breast cancer (Figure 7C). This evidence concerns the gene EGFR and breast carcinoma.